Market Overview:
The global thyroid function test market size reached US$ 1.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.96% during 2023-2028.
Thyroid function tests are used to measure the levels of hormones in the blood. They help healthcare professionals diagnose diseases like thyroiditis, nodules, cancer, tumors, goiter, Graves’, Hashimoto’s, hyperthyroidism, and hypothyroidism. Some of the tests advised by doctors to evaluate thyroid function include triiodothyronine (T3), thyroxine (T4), calcitonin, thyroglobulin, thyroid antibody, and thyroid-stimulating hormone (TSH). Presently, there is a rise number of infants with elevated thyrotropin receptor autoantibodies (TRAb), advanced bone age, and craniosynostosis are at a high risk of developing thyroid-related conditions. As a result, there is an increase in the demand for thyroid function tests to screen newborn babies for inherited problems with the thyroid gland.
Thyroid Function Test Market Trends:
Certain medications, such as amiodarone and lithium, and conditions like Type 1 diabetes, Coeliac, Addison's, Down's, and Turner syndrome increase the risk of developing thyroid. This, in confluence with a plethora of medical ailments and easy access to healthcare services, represents one of the significant factors positively influencing the need for thyroid function tests. Moreover, thyroid hormones maintain the functions of the brain, heart, muscles, and other organs and their under or overproduction can lead to serious health deteriorations. This, along with the increasing awareness about early diagnosis and improving diagnostic modalities, is contributing to market growth. Besides this, the growing geriatric population and considerable number of awareness campaigns supported by health agencies of numerous countries are driving the market for thyroid function tests. Furthermore, governments of various countries are planning to mandate newborn screening programs due to the rising prevalence of congenital conditions among infants. This, coupled with the increasing concerns among parents about the health of their children, is bolstering the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global thyroid function test market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on test type, indication and end user.
Breakup by Test Type:
- TSH Tests
- T3 Tests
- T4 Tests
- Others
Breakup by Indication:
- Hypothyroidism
- Hyperthyroidism
- Thyroid Cancer
- Others
Breakup by End User:
- Hospitals
- Diagnostic Laboratories
- Others
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Autobio Diagnostics Co. Ltd, bioMérieux SA, Diagnostic Automation/Cortez Diagnostics Inc., DiaSorin S.p.A., F. Hoffmann-La Roche AG, Merck KGaA, Qualigen Inc., Quidel Corporation, Siemens AG, and Thermo Fisher Scientific Inc.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2022 |
Historical Period |
2017-2022 |
Forecast Period |
2023-2028 |
Units |
US$ Billion |
Segment Coverage |
Test Type, Indication, End User, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Abbott Laboratories, Autobio Diagnostics Co. Ltd, bioMérieux SA, Diagnostic Automation/Cortez Diagnostics Inc., DiaSorin S.p.A., F. Hoffmann-La Roche AG, Merck KGaA, Qualigen Inc., Quidel Corporation, Siemens AG, and Thermo Fisher Scientific Inc. |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |